Purpose: The aim of this study was to evaluate early retinal damage after induction of ocular surface alkali burns and the protective effects of tumor necrosis factor alpha (TNF-a) blockade.
A lkali burns inflicted on the cornea often cause irreversible vision loss, even if promptly treated. [1] [2] [3] Surgical intervention, such as penetrating keratoplasty or limbal stem cell transplantation, can restore vision in some patients, but long-term results are usually disappointing. [4] [5] [6] [7] The keratoprosthesis (KPro), an artificial cornea made of plastic material, has proven to be effective in surgically restoring media transparency, although KPro procedures can sometimes cause postoperative complications. 3, 8, 9 Regardless, KPro surgery has frequently revealed unsuspected advanced glaucomatous damage to the optic nerve. Postoperatively, optic nerves of alkali-injured eyes also seem to be more vulnerable to glaucomatous degeneration, even at normal intraocular pressure (IOP) levels, which results in premature vision loss. 3 Thus, alkali injury to the ocular surface is not necessarily limited to the anterior structures, and it may also affect the posterior segment early and irreversibly. 8 The mechanisms of retina and retinal ganglion cell (RGC) damage after sustaining alkali burns remain largely unexplored, and treatment has generally only involved IOP reduction. 9 However, it has become difficult to explain progressive disk cupping, disk pallor, and vision loss based on IOP alone; therefore, other possible mechanisms resulting in retinal damage deserve evaluation. Two possible mechanisms of retinal damage after an ocular surface burn is inflicted can be hypothesized: (1) diffusion of inflammatory cytokines, especially tumor necrosis factor alpha (TNF-a) from the site of the injury to the posterior segment, causing cell death and retinal damage; and (2) direct pH-related alkali diffusion from the anterior chamber (AC) to the back of the eye, leading to cell cytotoxicity and retinal damage.
The aim of this study was to evaluate both hypotheses and to explore a novel therapeutic intervention.
METHODS

Animals
All animal-based procedures were performed in accordance with the Association For Research in Vision and Ophthalmology Statement for the use of Animals in Ophthalmic and Vision Research, and the National Institutes of Health Guidance for the Care and Use of Laboratory Animals. This study was approved by the Animal Care Committee of the Massachusetts Eye and Ear Infirmary.
Alkali Burns
Alkali burns were inflicted in 1 eye of BALB/c male mice (n = 94), 6 to 8 weeks old, using the following protocol: mice were anesthetized with ketamine (120 mg/kg) (Putney Inc, Portland, ME), and xylazine (20 mg/kg) (Vedco Inc, St Joseph, MO), diluted in normal saline and administered intraperitoneally (IP), and placed under the surgical dissecting microscope in a laterally recumbent position. A single topical proparacaine 0.5% (Ophthalmic Solution) eye drop was applied to the cornea, followed by the application of 1 N NaOH with filter paper (3-mm diameter) for 20 seconds. After inflicting the burn, the eye was thoroughly irrigated with saline solution for 15 minutes. Buprenorphine hydrochloride (0.05 mg/kg) (Buprenex Injectable, Reckitt Benckiser Healthcare Ltd, United Kingdom) was administered subcutaneously for pain management. Topical medication included a single drop of Polytrim antibiotic (polymyxin B/trimethoprim, Bausch & Lomb Inc, Bridgewater, NJ) applied daily. Both eyes from 5 additional mice were used as negative controls (unburned eyes).
Ocular Damage Assessment
Alkali burned eyes (n = 40) were enucleated 15 minutes, 60 minutes, 24 hours, 72 hours, and 7 days after the burn (n = 8 in each group). The eyes were stored in 4% paraformaldehyde for 3 hours and processed for cryosections. Corneal and retinal damage was evaluated using the In Situ Cell Death Detection Kit, TMR Red assay, and 49,6-diamidino-2-phenylindole (DA-PI) for nucleus labeling. The presence of inflammatory cells in tissue sections was assessed by means of immunolocalization using polyclonal anti-CD45 antibody (Abcam ab10558), fluorescent conjugated secondary antibody (Abcam Donkey antirabbit IgG H&L DyLight 488), and DAPI. Corneal neovascularization (NV) was calculated using ImageJ (Wayne Rasband, National Institute of Health). Two unburned mice (n = 4) were used as negative controls.
TNF-a Blockade
TNF-a blockade was performed in 27 mice, 15 minutes after the alkali burns were inflicted, using a single injection of Infliximab (6.25 mg/kg) (Janssen Biotech, Horsham, PA) given IP. For the isotype control group, human IgG1 kappa isotype antibody (6.25 mg/kg) (GeneTex, Irvine, CA) was administered IP in additional 27 mice, to distinguish nonspecific binding from antigen-specific antibody effects. Eighteen mice treated with TNF-a inhibitor and 18 treated with IgG isotype antibody were assessed for corneal and retinal apoptoses, immune cell infiltration, and corneal NV at 1 (n = 9), 3 (n = 9), 7 (n = 9), and 14 (n = 9) days postburn. The remaining 18 mice were assessed for cytokine expression. The 2 unburned mice (n = 4) from the previous experiment were used as negative controls.
Cytokine Expression
Posterior segment cytokine and corneal NV analysis was performed in mice whose eyes were burned and treated with TNF-a inhibitor (n = 9) or IgG isotype antibody (n = 9) at 1 (n = 6), 3 (n = 6), and 7 (n = 6) days postburn.
The analysis was performed using the enzyme-linked immunosorbent assay (ELISA), Q-Plex technology (Quansys Biosciences', Logan, UT). To achieve a sufficient ELISA signal, 3 retinas from each group were homogenized together and suspended in lysis buffer of 1000 mL of complete lysis-M (Roche Applied Science) and 40 mL of protease inhibitor (Roche Applied Science). Samples were assayed in triplicate for IL1b, IL2, IL6, TNF-a, CCL5, and macrophage inflammatory protein (MIP)-1a protein levels. Negative control eyes (n = 9) were treated similarly.
pH Measurements
To assess the degree of alkali penetration into the eye, AC, and vitreous, pH measurements were taken in rabbits (in vivo) and in porcine explanted eyes. These species were selected for their size, to accommodate the implantable pH probe because mouse eyes are too small to accurately measure pH.
In vivo pH measurements were performed in 4 rabbits, which were anesthetized subcutaneously for 2 hours, using 1 mL of ketamine (40 mg/kg) and xylazine (10 mg/kg). For the implantation of the pH probe, standard aseptic precautions were used, and a lid retractor was placed in the eye. A pH microelectrode (needle combination pH microelectrodes, Bedford, NH) was inserted into the vitreous cavity for realtime, intraocular pH measurements and secured using a scleral suture. Alkali burns were inflicted using 500 mL of 2 N NaOH solution applied to the cornea using a 9-mm trephine for 30 seconds. The alkali was then removed using a filter paper, and the eye was thoroughly irrigated for 15 minutes with saline solution. The animals were kept under deep anesthesia for 2 hours and euthanized at the end of the experiment. In a similar fashion, pH measurements in the AC and vitreous were performed in 4 explanted porcine eyes (n = 4) for a period of 75 minutes.
RESULTS
Evaluation of Corneal Damage After Induction of Alkali Burns
Corneal damage was assessed in burned mouse eyes to confirm the induction of alkali injury. In particular, terminal deoxynucleotidyl transferase 29-deoxyuridine 5 -triphosphate nick end labeling (TUNEL) and CD45 assays were performed in corneal tissue, whereas long-term assessment included measurements of corneal NV. Twenty-four hours postburn, the cornea exhibited generalized cell apoptosis and infiltration of immune cells (CD45+), confirming the induction of the alkali injury ( Fig. 1 ). Over time, corneal NV progressed and reached 90% of the cornea surface area on day 14.
TUNEL+ labeling compared with that observed in control eyes, with 88 6 4.45% of the RGC cells being TUNEL positive. This effect followed a gradual decline on days 3 and 7, with the RGC exhibiting less TUNEL+ labeling on day 3 (11.64 6 9.45%) and on day 7 (44.49 6 44.3%) ( Fig. 2) . RGC death was associated with increased inflammatory infiltrate on days 1 and 7, as judged by labeling with anti-CD45 antibody (Fig. 3 ). However, on day 3 postburn, FIGURE 2 . Cell apoptosis in mouse retinas after corneal alkali burn induction with NaOH. TUNEL immunolocalization (red) and nuclei labeling was done with DAPI (blue). A, No apoptosis was detected 15 and 60 minutes after the burn induction. However, 24 hours after the burn induction, the RGC layer (arrow) and the inner plexiform layer showed marked apoptosis. TUNEL labeling was significantly reduced on days 3 and 7 postburn, and limited only at the RGC layer. B, Quantification of TUNEL labeling calculated as the total count of red cells (TUNEL) divided by the total count of blue cells (DAPI), multiplied by 100. CD45+ cell infiltrates showed a marked reduction compared with that on days 1 and 7.
Corneal Alkali Burn Results in Retinal Inflammatory Cytokine Upregulation
Several inflammatory cytokines have been implicated in alkali-induced injury, such as IL1b, IL2, IL6, TNF-a, MIP-1a, and CCL5. Analysis of homogenized posterior segments revealed a drastic increase in the levels of all cytokines tested 24 hours after inducing the alkali burn, followed by a gradual decrease to undetectable levels by day 7 (Fig. 4 ).
TNF-a Blockade Is Beneficial After Corneal Alkali Burn Induction
Given the observed effects of alkali burn on TNF-a levels, we wanted to determine whether TNF-a blockade reduces ocular injury. A single administration of TNF-a inhibitor IP 15 minutes after inducing the burn considerably reduced RGC TUNEL+ cells compared with that in the control IgG-treated group at all time points (Figs. 5, 6 ). Corneal NV was reduced by 27% on day 5 (P , 0.01), 24% on day 7 (P , 0.05), and 52% on day 14 (P , 0.05) (Fig. 5 ). In addition, TNF-a inhibition causes a marked reduction in cornea TUNEL+ cells compared with that in isotype controls on day 14 (Fig. 7) .
DISCUSSION
For many patients, recent improvements in corneal and limbal stem cell transplantation, and KPro surgery, have resulted in a long-lasting restoration of corneal transparency after chemical burns. However, other patients experience disappointing visual outcomes shortly after reparative surgery, or a slow deterioration after achieving good initial visual acuity. 3 Injury to posterior structures after alkali burn induction, such as to the optic nerve and retina, may play a greater role in vision loss than was originally suspected.
In this study, we demonstrated that alkali burns to the cornea lead not only to corneal damage but also to retinal damage with RGC layer apoptosis occurring within 24 hours. Two possible reasons for these events were considered: (1) diffusion of alkali to the posterior segment and (2) diffusion of inflammatory cytokines posteriorly, generated in the anterior segment.
Unfortunately, there are technical limitations in measuring the pH in the eyes of mice in vivo because of their small size. In pilot in vivo and ex vivo experiments that used larger eyes from pigs and rabbits, direct pH measurements revealed that the alkalinity in the AC was significantly elevated within 10 minutes of burn induction. The pH increased from 7.11 6 0.20 to 11.98 6 0.12, P , 0.01, signifying a rapid diffusion of alkali ions into the AC. In contrast, pH measurements in the vitreous remained unchanged for 2 hours in rabbits (before burn, pH = 6.87 6 0.08; after burn, pH = 6.88 6 0.08; P . 0.865) and 75 minutes in porcine eyes (before burn, pH = 7.44 6 0.35; after burn, pH = 7.48 6 0.29; P = 0.84). These findings suggest that prompt alkali diffusion posteriorly through the vitreous is very unlikely, at least in large eyes. This supports the findings of published studies with similar results, indicating rapid pH elevation in the AC, and no pH change in the vitreous cavity for 3 hours after burn induction. 10 The ability of the vitreous to maintain its physiological pH, even in the presence of AC pH elevation, is likely because of the buffering capacity of the crystalline lens and the iris. 10 However, it is possible that there may be flow through the peripheral ocular tissues, which requires further investigation. We cannot reject the possibility . Cytokine expression in the posterior segment of the eye after inflicting the alkali burn on the cornea. Cytokine analysis included IL1b, IL2, IL6, TNF-a, MP1-a, and chemokine C-C motif ligand 5 (CCL5) using the ELISA technique. Burned eyes were enucleated on days 1, 3, and 7 postburn, and only the posterior segment of the mouse eyes was used. Three eyes of the same group were homogenized together to increase protein content. Three nonburned mouse eyes were used as the control. Note that all inflammatory cytokines exhibited a marked increase on day 1 postburn. Cytokine levels had returned to normal levels on days 3 and 7. The y axis represents the adjusted average analyte concentration (picograms per milligrams) of cytokines. that alkali diffusion may take place in mouse eyes, which are significantly smaller than rabbit and porcine eyes. This possibility should be investigated, given the attempt to use mice as a model for human alkali ocular injuries. The effects of cytokine diffusion and retinal damage in larger eyes, such as those of rabbits, should also be studied to establish the relationship between mice and rabbit models. Further experiments conducted by our group are currently underway and are based on rabbits in an attempt to assess the role of eye volume in posterior alkali diffusion and retinal damage.
When we examined the levels of interleukin (IL)1b, IL2, IL6, TNF-a, CCL5, and MIP-1a cytokines in the posterior segment, we observed a significant elevation 24 hours postburn, coinciding with the peak of apoptosis in the RGC layer. These findings confirm similar results that have been previously reported. 11 We also observed a second wave of RGC apoptosis 7 days after the burn induction. This finding coincides with the clinical course of ocular chemical injury, which is divided into the acute (0-7 days) and the early reparative phases (8-20 days). 12 We believe that day 1 RGC apoptosis is mediated by the acute phase, whereas day 7 apoptosis is attributed to the early reparative phase and the inflammation from digestive enzymes, such as metalloproteinase and other proteases released from the regenerating cornea epithelium and T-cells. However, the scope of this study was to determine the initiation of RGC apoptosis and provide prompt protection with infliximab.
The role of TNF-a in retinal damage and RGC apoptosis is of significant interest in our model. TNF-a is a pluripotent cytokine 13 that can initiate the caspase cascade and cell apoptosis. 14 Inhibition of TNF-a has been successfully used for a number of inflammatory diseases of the eye, such as in Behcet disease, 15 diffuse subretinal fibrosis syndrome, 16 posterior scleritis, 17 retinal vascular tumors, 18 and photoreceptor degeneration in retinal detachment. 13 Prevention of RGC loss in rat glaucoma models has also been elegantly demonstrated using TNF-a blockade. 19 In our study, the inhibition of TNF-a was attempted to protect against retinal damage after induction of ocular surface alkali injury. A single dose of a monoclonal anti-TNF-a was administered 15 minutes after the alkali exposure, and resulted in a significant inhibition of retinal apoptosis compared with that in the control IgG isotype. Our study also showed that administration of anti-TNF-a antibody given IP provides significant corneal protection and reduction of corneal NV. This corresponds with the findings of another recent study on alkali burns in mice, where the topical application of infliximab resulted in a reduction of corneal cell apoptosis and NV. 20 To our knowledge, our study is the first to demonstrate retinal and RGC apoptosis after alkali burn induction, and considerable protection by the prompt delivery of a single dose of TNF-a inhibitor. These results suggest that TNF-a inhibition -administered within 15 minutes of induction of an alkali injury-could potentially provide patients with much needed protection against retinal damage. Moreover, preventing damage early on combined with later surgical interventions, such as KPro surgery, may be paradigm changing in the therapy of severe chemical burns. Further, this study confirms our hypothesis of inflammatory cells being responsible for RGC apoptosis after infliction of alkali burn on the cornea.
One of the study limitations was the lack of in vivo measurements of vitreous pH in mouse eyes. Further studies are required to elucidate the vitreous pH 24 hours after burn induction. Such experiments will require prolonged sedation, FIGURE 6. Corneal NV with IgG control and with infliximab, 1 and 14 days postburn and quantification. A, Note the significant reduction in corneal NV with infliximab on day 14. Cornea opacity and cataract formation, however, were similar in both treatment groups. Corneal opacity was attributed to stromal scaring and corneal edema because of endothelial decompensation. In the infliximab group, the lack of corneal NV and inflammation allowed the visualization of the underlying cataract, which gave the false impression of increased corneal opacity compared with that in the IgG group. B, Quantification of corneal NV in infliximab-or IgG-treated mice 1, 3, 5, 7, 10, and 14 days postburn. Mice treated with infliximab exhibited significantly less NV than did IgG-treated mice. and the use of miniaturized implantable pH sensors, capable of maintaining ocular tone and minimizing trauma. It is not clear whether smaller eyes can prevent alkali diffusion posteriorly, as rabbit and porcine eyes can. Further studies carried out by our group are underway and are based on miniaturized implantable pH sensors for pH measurements in such critically small eyes.
In conclusion, this study suggests that alkali burns inflicted on the cornea can elicit the expression of destructive inflammatory cytokines, not only in the anterior segment but also in the posterior segment, leading to retinal damage within 24 hours. TNF seems to play a critical role, and TNF-a inhibition may offer substantial protection for both the cornea 19 and posterior segment (as demonstrated in this study). These findings may have practical implications when patients with alkali burns arrive at the emergency room. Perhaps, in addition to ocular lavage, systemic TNF-a inhibitors may be considered.
